Default company panoramic image

Ascendant Diagnostics Inc.

A more accurate, less expensive, non-invasive test for breast cancer using two drops of tears.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Fayetteville, AR, USA
  • Currency USD
  • Founded January 2011
  • Employees 3
  • Website

Company Summary

Ascendant Diagnostics mission to develop new approaches to the diagnosis of serious diseases. The company's first product, MelodyDx, currently under development is a screening test that can detect the presence of early stage breast cancer using the protein profile in a patients tears.


  • Default avatar
    Omid Moghadam
    CEO and Chairman

    I am an experienced executive, entrepreneur and inventor. I have spent the last 18 years bringing new products and businesses to market in fields ranging from photography, medical imaging, and microprocessors to graphics, healthcare information technology and genomics.

    I specialize in finding markets for new technologies, or finding new markets for old technologies.

  • Default avatar
    Anna Daily
    Chief Science Officer

    Dr. Daily provides expertise in the expression and purification of recombinant proteins, genetic engineering / cloning, and numerous biophysical and analytical chemistry techniques towards the characterization of proteins.

  • Default avatar
    Patricia Beckman
    Product Development Consultant

    Entrepreneurially-driven bioscience professional with experience in multiple disciplines. Identification of novel and disruptive technologies, creating novel business models. Qualified operational manager effective in leading early-stage companies. Broad network of relationships. Professional reputation for integrity, creativity, communication, building teams and adding value.

  • Default avatar
    Suzanne Klimberg
    Medical Director

    Dr. Suzanne Klimberg, is a world renowned breast surgical oncologist who discovered breast cancer protein patterns in tears. Dr. Klimberg is the Director of the Breast Cancer Program at the Winthrop P. Rockefeller Cancer Institute and the Muriel Balsam Kohn Chair in Breast Surgical Oncology, UAMS. Additionally, Dr. Klimberg is a professor of Surgery and Pathology for the University of Arkansas for Medical Sciences in Little Rock, Arkansas, and th


  • Default avatar
    Jim Smith, Smith Hurst LLC, Fayetteville, AR
    Default avatar
    Frost, PLLC

Previous Investors

  • Default avatar
    Arkansas Science & Technology Authority ($100k)
    Default avatar
    Arkansas Development Fund Authority ($100k)
    Default avatar
    Individual Investors ($250k)